首页 蛋白库 基因库 产品 会员服务
位置：首页 > 产品库 > Safinamide
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Safinamide
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Safinamide图片
CAS NO:133865-89-1

Safinamide 是一种强效、选择性和可逆的单胺氧化酶 B (MAO-B) 抑制剂 (IC50=0.098 μM)，优于 MAO-A (IC50=580 μM)。
Cas No.133865-89-1
别名沙芬酰胺; FCE 26743; EMD 1195686
化学名(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
Canonical SMILESCC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
分子式C17H19FN2O2
分子量302.34
溶解度Soluble in DMSO
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Safinamide (FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A[1].

Safinamide (FCE 26743) is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide (FCE 26743) is voltage-dependent sodium and calcium channel blocker. Safinamide (FCE 26743) appears to bind to the batrachotoxin-sensitive site 2 of the voltage-sensitive sodium channels. Safinamide blocks N and L-type calcium channels and inhibits glutamate and aspartate release from synaptic terminals[1].

References:
[1]. Leonetti F, et al. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase. J Med Chem, 2007, 50(20), 4909-4916.
[2]. Schapira AH.Safinamide in the treatment of Parkinson's disease.Expert Opin Pharmacother. 2010 Sep;11(13):2261-8.
[3]. Onofrj M, et al. An expert opinion on safinamide in Parkinson's disease.Expert Opin Investig Drugs. 2008 Jul;17(7):1115-25.
[4]. Chazot PL.Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.Curr Opin Investig Drugs. 2007 Jul;8(7):570-9.
[5]. Dal Bo L, et al. Bioassay of safinamide in biological fluids of humans and various animal species.Arzneimittelforschung. 2006;56(12):814-9.http://www.ncbi.nlm.nih.gov/pubmed/17260668

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025